Presentations from the Virtual Global Summit on Precision Diagnosis
and Treatment of Prostate Cancer

SESSION I: Patient Population Prior to Dx of PC: Improving Risk Assessment, Patient Selection for Biopsies and Tissue Sampling

SESSION I: Patient Population Prior to Dx of PC: Improving Risk Assessment, Patient Selection for Biopsies and Tissue Sampling

Faina Shtern, MD, presented opening remarks for Session I at the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 1, 2020.

Liquid Diagnostics

E. David Crawford, MD , presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 1, 2020.

miR Scientific Sentinel Assay

Laurence Klotz, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 1, 2020.

Current and Emerging Imaging Tools for Improving Risk Assessment and Selection of Patients for Biopsy

Clare Tempany, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 1, 2020.

High Resolution Micro Ultrasound

Laurence Klotz, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 1, 2020.

Update of Changes in the Early Detection of Prostate Cancer NCCN Guidelines 2020

Preston Sprenkle, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 1, 2020.

Integrated Multi-Modality Diagnostic Evaluation

Sanoj Punnen, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 1, 2020.

SESSION II: Population of Men with Localized Disease (Initial & Recurrent): Clinical Evaluation and Selection of Appropriate Treatment

SESSION II: Population of Men with Localized Disease (Initial & Recurrent): Clinical Evaluation and Selection of Appropriate Treatment

Faina Shtern, MD, presented opening remarks for Session II at the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2020.

Evaluation and Management of Localized and Recurrent Prostate Cancer: Genetic Cancer Profiling

Allan Pollack, MD, PhD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2020.

Germline Genome and Prostate Cancer Evolution and Aggressivity

Paul Boutros, MD, PhD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2020.

Current Clinical Utility of MRI and Multi-Modality Imaging

Masoom Haider, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2020.

Non-Invasive Molecular Imaging and its Impact on Management of the Localized Disease and Suspected Recurrence

Andrei H. Iagaru, MD, FACNM, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2020.

Biomarkers and Their Integration with Clinical Parameters, Imaging and Prognostic Instruments for Clinical Decisions

Matthew R. Cooperberg, MD, MPH, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2020.

Role of MR-targeted Prostate Biopsy in Active Surveillance

Behfar Ehdaie, MD, MPH, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2020, in Boston, MA.

Integration of Systemic Therapy and Surgery in 2020

Adam Kibel, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 8, 2020.

SESSION III: Precision Oncology of Advanced Prostate Cancer: Defining Regional, Oligometastatic and Systemic Disease – and Reviewing Theranostics

SESSION III: Precision Oncology of Advanced Prostate Cancer: Defining Regional, Oligometastatic and Systemic Disease – and Reviewing Theranostics

Faina Shtern, MD, presented opening remarks for Session III at the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 15, 2020.

Precision Oncology of Advanced Prostate Cancer

Angelo DeMarzo, MD, PhD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 15, 2020.

Systemic Disease and Circulating Tumor Cells

David Nanus, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 15, 2020, in Boston, MA.

Precision Diagnosis – Defining Non-Metastatic and Oligometastatic Prostate Cancer vs. Systemic Disease

Jeremie Calais, MD, MSc, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 15, 2020.

Molecular and Multi-Modality Imaging and Theranostics of Prostate Cancer – Current State of the Art

Wolfgang Weber, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 15, 2020.

Future Directions in Molecular and Multi-Modality Imaging and Theranostics of Prostate Cancer

Philip Koo, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 15, 2020.

SESSION IV: Minimally-Invasive, Image-Targeted Treatment: Patient Selection, Target Definition, Monitoring and Outcomes

SESSION IV: Minimally-Invasive, Image-Targeted Treatment: Patient Selection, Target Definition, Monitoring and Outcomes

Faina Shtern, MD, presented opening remarks for Session IV at the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 22, 2020.

Overview of Image-Guided, Minimally-Invasive Focal Treatment

Jim Hu, MD, MPH, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 22, 2020.

Radiation Oncology Perspective on the Role of Multi-Modality and Molecular Imaging in Target Definition

Jason A. Efstathiou, MD, DPhil, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 22, 2020.

Current and Emerging Role of Radiogenomics in Risk Assessment

John Feller, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 22, 2020.

Image-Guided Minimally-Invasive Whole Gland Treatment

Steven Raman, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 22, 2020.

High Intensity Focal Ultrasound and Other Focal Interventions – Emerging Data and Clinical Utility vs. Standard Care (Active Surveillance and Whole-Gland Treatment with Surgery and Radiation)

Andre Abreu, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 22, 2020.

Closing Remarks from the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer

Faina Shtern, MD, presented this lecture during the Virtual Global Summit on Precision Diagnosis and Treatment of Prostate Cancer on October 22, 2020.